ArchiMed invests in buyout and growth capital transactions, across all European countries, focusing specifically on growing companies.
The investment team is made up of investment professionals who, for the most part, have led or worked with the 3i Healthcare team during the past decade. The team has invested over 1 billion euros in healthcare companies, in Northern America, Europe and Asia
Amounts invested are typically between 5M€ and 60M€ per transaction, which can be extended to higher levels with the support of ArchiMed’s investors.
ArchiMed invests in all four major healthcare segments:
- Care and Wellness
- Public Health
Over 10,000 companies are active in these areas in Europe and represent a combined turnover in excess of 100bn€.
We invest on the basis of business projects defined by leading management teams to whom we bring our network of contacts, our experience and capital.
We work intensely with them to accelerate the growth of their businesses through the development of their product and service offerings as well as their geographic expansion.
Our network in the healthcare sector is available to all of ArchiMed’s partnering companies. It provides:
• Contacts in major groups in the healthcare sector that may become key accounts
• Access to regulators as well as both public and private payers
• Additional management resources for existing or future international businesses.